Reflux Esophagitis (Gastroesophageal Reflux Disease) Market Statistics, Size, Share, Pipeline Review, H1 2016

Reflux Esophagitis (Gastroesophageal Reflux Disease)

Market Size, Share, Pipeline Review, H1 2016

Summary

Global Markets Direct's, 'Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1

2016', provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease) pipeline

landscape.

The report provides comprehensive information on the therapeutics under development for Reflux

Esophagitis (Gastroesophageal Reflux Disease), complete with analysis by stage of development, drug

target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also

covers the descriptive pharmacological action of the therapeutics, its complete research and

development history and latest news and press releases. Additionally, the report provides an overview

of key players involved in therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux

Disease) and features dormant and discontinued projects.

Click for Report Details @ http://www.radiantinsights.com/research/reflux-esophagitisgastroesophageal-reflux-disease

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy

areas and nearly 3,000 indications. The report is built using data and information sourced from Global

Markets Direct's proprietary databases, company/university websites, clinical trial registries,

conferences, SEC filings, investor presentations and featured press releases from company/university

sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic

review following a stringent set of processes to ensure that all the profiles are updated with the latest

set of information. Additionally, various dynamic tracking processes ensure that the most recent

developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios,

enhances decision making capabilities...